| Literature DB >> 21457949 |
Tom S Scerri1, Andrew P Morris, Lyn-Louise Buckingham, Dianne F Newbury, Laura L Miller, Anthony P Monaco, Dorothy V M Bishop, Silvia Paracchini.
Abstract
BACKGROUND: Several susceptibility genes have been proposed for dyslexia (reading disability; RD) and specific language impairment (SLI). RD and SLI show comorbidity, but it is unclear whether a common genetic component is shared.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21457949 PMCID: PMC3139836 DOI: 10.1016/j.biopsych.2011.02.005
Source DB: PubMed Journal: Biol Psychiatry ISSN: 0006-3223 Impact factor: 13.382
Figure 1Diagram illustrating how phenotypic subgroups were identified. The subgroups above the black horizontal lines were used for quantitative analysis while the ones below were used for case-control analysis. The extent of co-morbidity (hence the non-mutually exclusive definition of cases), can be seen in Figure 2. ADHD, attention-deficit/hyperactivity disorder; CCC_SUM7, sum of first seven scales from the Children's Communication Checklist; PERF_IQ, performance IQ; RD, reading disability; SLI, specific language impairment.
Affection Status Groups of All the Individuals from F1
| Affection Status | Frequency | % |
|---|---|---|
| Unaffected | 3283 | 88.13 |
| RD | 171 | 4.59 |
| SLI | 186 | 4.99 |
| ADHD | 26 | .70 |
| RD and SLI | 46 | 1.23 |
| RD and ADHD | 5 | .13 |
| SLI and ADHD | 5 | .13 |
| RD, SLI, and ADHD | 3 | .08 |
ADHD, attention-deficit hyperactivity disorder; RD, reading disability; SLI, specific language impairment.
Figure 2A Venn diagram illustrating the distributions of the cases identified for reading disabilities (RD), specific language impairment (SLI), and attention-deficit/hyperactivity disorder (ADHD) from Sample F1. Circle size is proportional to sample size, and circle overlaps represent comorbidity.
Description of Phenotypic Measures
| Measure | Assignment/Phenotype | Summary Description | Target Age | Reference |
|---|---|---|---|---|
| READ | A/P | Single-word reading accuracy | 7.5 year | |
| READ@9 | A | Single-word reading accuracy | 9.5 year | |
| SPELL | P | Single-word spelling accuracy | 7.5 year | |
| PHONEME | P | Phoneme awareness | 7.5 year | |
| NW-READ | P | Single-non-word reading accuracy | 9.5 year | |
| MEMSPAN | P | Working memory | 10.5 year | |
| WOLD | A/P | Listening and comprehension test | 8.5 year | |
| NW-REPT | A/P | Phonological short-term memory test | 8.5 year | |
| CCC-SUM7 | A/P | Sum of first seven scales from Children's Communication Checklist | 7.5 year | |
| Speech/language therapy | A | Child has ever had speech/language therapy | 7.6 year | |
| DAWBA DSM-IV | A | Attention-deficit hyperactivity disorder diagnosis | 7.6 year−8.5 year | |
| PERF_IQ | A | Performance IQ | 8.5 year |
See Table S1 in Supplement 1 for more details.
Specifies whether the measure was used for assignment (A) of case status or as phenotype (P) for quantitative analysis.
Core measure for RD.
Core measure for specific language impairment.
Associations Results of the 19 SNPs Tested in F1 with READ and NW_REPT
| READ | NW-REPT | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chr. | Gene Locus | SNP | β | SE | β | SE | Risk Allele | ||||
| 2 | rs1000585 | 3,050 | .00 | .03 | .972 | 3,048 | .00 | .03 | .928 | ||
| 2 | rs917235 | 3,165 | .00 | .03 | .949 | 3,163 | −.02 | .03 | .353 | ||
| 2 | rs714939 | 3,041 | .02 | .03 | .427 | 3,039 | .01 | .03 | .646 | ||
| 6 | rs793862 | 3,117 | −.08 | .03 | .006 | 3,115 | −.06 | .03 | .031 | A (minor) | |
| 6 | rs807701 | 3,193 | −.05 | .03 | .033 | 3,191 | −.03 | .03 | .185 | G (minor) | |
| 6 | rs807724 | 3,085 | −.07 | .03 | .015 | 3,083 | −.03 | .03 | .257 | C (minor) | |
| 6 | rs1087266 | 3,198 | −.03 | .03 | .219 | 3,196 | .00 | .03 | .915 | ||
| 6 | rs761100 | 3,190 | −.03 | .03 | .211 | 3,188 | −.01 | .03 | .603 | ||
| 6 | rs6935076 | 3,006 | .07 | .03 | .011 | 3,004 | .02 | .03 | .482 | G (major) | |
| 6 | rs2038137 | 3,053 | −.02 | .03 | .374 | 3,051 | −.02 | .03 | .544 | ||
| 6 | rs9461045 | 3,126 | −.08 | .03 | .024 | 3,124 | −.03 | .03 | .368 | T (minor) | |
| 6 | rs2143340 | 3,042 | −.11 | .04 | 3,040 | −.04 | .04 | .242 | G (minor) | ||
| 16 | rs12927866 | 3,055 | −.07 | .03 | .005 | 3,053 | −.04 | .03 | .136 | T (minor) | |
| 16 | rs6564903 | 3,157 | −.08 | .02 | .002 | 3,155 | −.02 | .02 | .360 | T (minor) | |
| 16 | rs4265801 | 3,052 | .02 | .03 | .449 | 3,050 | .03 | .03 | .289 | ||
| 16 | rs16955705 | 3,050 | −.06 | .03 | .029 | 3,048 | −.02 | .03 | .482 | C (minor) | |
| 16 | rs16973771 | 3,009 | .01 | .03 | .691 | 3,007 | .02 | .03 | .493 | ||
| 16 | rs2875891 | 3,049 | .00 | .03 | .950 | 3,047 | .02 | .03 | .458 | ||
| 16 | rs8045507 | 3,046 | .00 | .03 | .979 | 3,044 | .01 | .03 | .588 | ||
Only one p value was statistically significant (< .0023; Methods in Supplement 1) and is highlighted in bold; β (beta) values are standardized and relative to the minor allele (as defined in Table S3 in Supplement 1). Risk allele is reported only for markers showing p values < .05.
SNP, single nucleotide polymorphism.
Opposite trend compared with original reports (24,36).
Within TTRAP.
Summary of Results Showing Association (p < .05) with Quantitative Measures
| Chr. | Gene Locus | SNP | F1 | F2 | F3 | F4: Unaffected | Risk Allele | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| READ | |||||||||||||||||||
| N | β | SE | P | N | β | SE | P | N | β | SE | P | N | β | SE | P | ||||
| 6 | rs793862 | 3,117 | –.08 | .03 | .006 | 2,936 | –.09 | .03 | .004 | 2,890 | –.08 | .03 | .010 | 2,740 | –.06 | .03 | .042 | A (minor) | |
| 6 | rs807701 | 3,193 | –.05 | .03 | .033 | 3,003 | –.04 | .03 | .090 | 2,954 | –.03 | .03 | .276 | 2,803 | –.02 | .02 | .376 | G (minor) | |
| 6 | rs807724 | 3,085 | –.07 | .03 | .015 | 2,898 | –.07 | .03 | .018 | 2,850 | –.05 | .03 | .091 | 2,700 | –.02 | .03 | .422 | C (minor) | |
| 6 | rs6935076 | 3,006 | .07 | .03 | .011 | 2,831 | .08 | .03 | .003 | 2,784 | .07 | .03 | .006 | 2,646 | .05 | .02 | .028 | G (major) | |
| 6 | rs9461045 | 3,126 | –.08 | .03 | .024 | 2,947 | –.08 | .03 | .026 | 2,901 | –.08 | .03 | .022 | 2,752 | –.05 | .03 | .162 | T (minor) | |
| 6 | rs2143340 | 3,042 | –.11 | .04 | 2,864 | –.12 | .04 | 2,817 | –.12 | .04 | 2,677 | –.11 | .03 | G (minor) | |||||
| 16 | rs12927866 | 3,055 | –.07 | .03 | .005 | 2,874 | –.08 | .03 | .004 | 2,829 | –.07 | .03 | .005 | 2,690 | –.07 | .02 | .005 | T (minor) | |
| 16 | rs6564903 | 3,157 | –.08 | .02 | .002 | 2,966 | –.08 | .03 | 2,919 | –.08 | .03 | 2,768 | –.07 | .02 | .002 | T (minor) | |||
| 16 | rs16955705 | 3,050 | –.06 | .03 | .029 | 2,869 | –.06 | .03 | .022 | 2,824 | –.06 | .03 | .019 | 2,684 | –.05 | .02 | .027 | C (minor) | |
| SPELL | |||||||||||||||||||
| 6 | rs793862 | 3,094 | –.09 | .03 | .003 | 2,913 | –.09 | .03 | .003 | 2,871 | –.08 | .03 | .009 | 2,729 | –.06 | .03 | .030 | A (minor) | |
| 6 | rs807724 | 3,065 | –.08 | .03 | .007 | 2,878 | –.08 | .03 | .011 | 2,834 | –.06 | .03 | .050 | 2,691 | –.04 | .03 | .204 | C (minor) | |
| 6 | rs2143340 | 3,023 | –.10 | .04 | .004 | 2,845 | –.10 | .04 | .005 | 2,802 | –.11 | .04 | .004 | 2,669 | –.10 | .04 | .006 | G (minor) | |
| 16 | rs12927866 | 3,036 | –.06 | .03 | .014 | 2,855 | –.07 | .03 | .009 | 2,814 | –.07 | .03 | .011 | 2,682 | –.06 | .03 | .014 | T (minor) | |
| 16 | rs6564903 | 3,136 | –.07 | .02 | .008 | 2,945 | –.07 | .03 | .003 | 2,901 | –.07 | .03 | .004 | 2,758 | –.07 | .02 | .008 | T (minor) | |
| 16 | rs16955705 | 3,030 | –.06 | .03 | .026 | 2,849 | –.06 | .03 | .019 | 2,808 | –.06 | .03 | .017 | 2,675 | –.06 | .03 | .027 | C (minor) | |
Only SNPs showing p values < .05 in any group tested are reported; p values statistically significant (< .0023; Methods in Supplement 1) are in bold; β (beta) values are standardized and relative to the minor allele (as defined in Table S3 in Supplement 1).
SNP, single nucleotide polymorphism.
Opposite trend compared with original reports (24,36).
Within TTRAP.
Summary of the Results of the Case−Control Analysis
| Chr. | Gene Locus | SNP | No. of Controls | SLI Only | SLI and Comorbid Cases | RD Only | RD and Comorbid Cases | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odds Ratio | Odds Ratio | Odds Ratio | Odds Ratio | Risk Allele | ||||||||||||
| 2 | rs917235 | 375 | 162 | .033 | 1.33 | 211 | .103 | 1.22 | 148 | .610 | 1.07 | 197 | .672 | 1.06 | G (minor) | |
| 6 | rs793862 | 375 | 155 | .418 | 1.13 | 201 | .101 | 1.26 | 150 | .021 | 1.42 | 196 | .005 | 1.47 | a (minor) | |
| 6 | rs807701 | 379 | 161 | .173 | 1.21 | 210 | .016 | 1.36 | 151 | .173 | 1.21 | 200 | .018 | 1.36 | G (minor) | |
| 6 | rs807724 | 371 | 158 | .754 | 1.05 | 206 | .146 | 1.24 | 150 | .035 | 1.40 | 198 | .003 | 1.52 | C (minor) | |
| 6 | rs6935076 | 363 | 149 | .993 | 1.00 | 196 | .661 | .95 | 138 | .026 | .72 | 185 | .011 | .71 | G (major) | |
| 6 | rs9461045 | 375 | 153 | .692 | 1.08 | 199 | .561 | 1.10 | 149 | .026 | 1.47 | 195 | .035 | 1.40 | T (minor) | |
RD, reading disability; SLI, specific language impairment; SNP, single nucleotide polymorphism.
Only SNPs showing p values < .05 in any of group tested are reported.
Opposite trend compared with original report (24).